Mitochondria have a major role in energy production via oxidative phosphorylation 1 , which is dependent on the expression of critical genes encoded by mitochondrial (mt)DNA. Mutations in mtDNA can cause fatal or severely debilitating disorders with limited treatment options 2 . Clinical manifestations vary based on mutation type and heteroplasmy (that is, the relative levels of mutant and wild-type mtDNA within each cell) 3, 4 . Here we generated genetically corrected pluripotent stem cells (PSCs) from patients with mtDNA disease. Multiple induced pluripotent stem (iPS) cell lines were derived from patients with common heteroplasmic mutations including 3243A.G, causing mitochondrial encephalomyopathy and stroke-like episodes (MELAS) 5 , and 8993T.G and 13513G.A, implicated in Leigh syndrome. Isogenic MELAS and Leigh syndrome iPS cell lines were generated containing exclusively wildtype or mutant mtDNA through spontaneous segregation of heteroplasmic mtDNA in proliferating fibroblasts. Furthermore, somatic cell nuclear transfer (SCNT) enabled replacement of mutant mtDNA from homoplasmic 8993T.G fibroblasts to generate corrected Leigh-NT1 PSCs. Although Leigh-NT1 PSCs contained donor oocyte wild-type mtDNA (human haplotype D4a) that differed from Leigh syndrome patient haplotype (F1a) at a total of 47 nucleotide sites, Leigh-NT1 cells displayed transcriptomic profiles similar to those in embryo-derived PSCs carrying wild-type mtDNA, indicative of normal nuclear-to-mitochondrial interactions. Moreover, genetically rescued patient PSCs displayed normal metabolic function compared to impaired oxygen consumption and ATP production observed in mutant cells. We conclude that both reprogramming approaches offer complementary strategies for derivation of PSCs containing exclusively wild-type mtDNA, through spontaneous segregation of heteroplasmic mtDNA in individual iPS cell lines or mitochondrial replacement by SCNT in homoplasmic mtDNA-based disease.
Maternally inherited mtDNA encodes 13 proteins critical for oxidative phosphorylation, while the remaining protein subunits are encoded by nuclear DNA. Therefore, mitochondrial biogenesis requires coordinated interaction of protein subunits encoded by both genomes 2 . Mutations in mtDNA occur at a higher rate than in nuclear DNA, resulting in life-threatening conditions 3, 6 . We have described a strategy to prevent transmission of mtDNA mutations to children involving mitochondrial replacement 7 . To explore the feasibility of generating genetically corrected autologous PSCs, herein, we focus on three of the most common pathogenic mtDNA mutations. Skin samples were donated by a MELAS patient carrying a 3243A.G heteroplasmic mutation in tRNA Leu (MT-TL1) 8 and by Leigh syndrome patients carrying heteroplasmic or homoplasmic 8993T.G mutations affecting the ATPase 6 gene (MT-ATP6) 3 , and heteroplasmic 13513G.A mutation in the MT-ND5 gene 9 . A panel of ten iPS cell lines from each mutation type was generated and quantitative mtDNA mutation analysis was carried out using amplification refractory mutation system-quantitative polymerase chain reaction (ARMs-qPCR), with a detection threshold of 0.5%. In MELAS iPS cell lines, the mutation was undetectable in five lines and varied from 33% to 100% in the remaining five lines, compared to 29% heteroplasmy in parental fibroblasts (Table 1 and Extended Data Fig. 1a ). In iPS cell lines from the heteroplasmic 8993T.G mutation, the mutation was undetectable in one line and ranged from 29% to 87% in the remaining lines, compared to 52% heteroplasmy in parental fibroblasts (Table 1 and Extended Data Fig. 1b) . Mutation segregation in individual iPS cell lines from 13513G.A fibroblasts also ranged from 0% to 100%, compared to 84% heteroplasmy in fibroblasts (Table 1 and Extended Data Fig. 1c ). Previous studies suggested that segregation of heteroplasmic mtDNA is specific to iPS cells and may occur during or after reprogramming 10, 11 . To explore mechanisms, parental fibroblasts carrying 3243A.G and 13513G.A mutations were subcloned and mutation loads in individual clones were analysed. Among ten randomly selected MELAS samples, five were homoplasmic containing either wild type (A) or mutant (G) at the 3243 position. The remaining five contained varying heteroplasmy levels similar to iPS cells (Table 1 and Extended Data Fig. 1d ). Variable heteroplasmy levels were also observed in 13513G.A fibroblasts including homoplasmic mutant and wild-type clones (Table 1) . Thus, segregation of heteroplasmic mtDNA mutations occurs in skin fibroblasts and may reflect a common phenomenon 12 . Isogeneic MELAS iPS cell lines carrying wild-type or mutant mtDNA maintained typical PSC morphology and formed teratomas containing cells and tissues from all three germ layers (Extended Data  Fig. 2a, b) . We next carried out whole mtDNA sequencing using the Illumina MiSeq platform and confirmed the 3243A.G mutation in parental MELAS-fib (46.8%), MELAS-iPS1 and MELAS-iPS3 (100%) cells while MELAS-iPS2 was homoplasmic for the wild-type allele (Supplementary Table 1 ). MELAS-fib also carried four additional heteroplasmic mutations with one variant carried to MELAS-iPS1 and MELAS-iPS2 (Supplementary Table 1 ).
The 3243A.G mutation perturbs tRNA Leu function and impairs mitochondrial protein synthesis as well as respiratory complex activity, with the homoplasmic mutation leading to prenatal lethality in humans 13 . Oxygen consumption rate (OCR) was employed as an indicator of mitochondrial respiration and energy production. Mutant MELAS-iPS1 and MELAS-iPS3 exhibited significantly lower OCR (P , 0.05) when compared to the wild-type MELAS-iPS2 (Fig. 1a) . Fibroblasts differentiated from MELAS-iPS1 and parental MELASfib also displayed low levels of mitochondrial function. In contrast, these respiratory defects were absent in MELAS-iPS2-derived fibroblasts. In general, mitochondrial respiration correlated with the heteroplasmy levels in cells (Fig. 1b and Table 1 ). The greater reliance on oxidative metabolism in wild-type MELAS-iPS2 was confirmed by the elevated OCR to ECAR (extracellular acidification rate) ratio, which provides a measure for the relative contribution of oxidative metabolism versus glycolysis (Extended Data Fig. 3a) . Mutant MELAS iPS cells and their derivatives displayed significantly decreased OCR/ECAR ratios, indicating a greater reliance on glycolysis (Extended Data  Fig. 3a, b) . We next differentiated MELAS iPS cells into neuronal progenitor cells (NPCs, Extended Data Fig. 3c, d ) 14, 15 . Diminished metabolic profiles in mutant NPCs recapitulated those observed in undifferentiated iPS cells (Extended Data Fig. 3e ). Cardiomyocyte differentiation 15 of mutant MELAS iPS cells was severely compromised due to massive cell death.
As expected, all iPS cell lines from homoplasmic 8993T.G fibroblasts carried mutant mtDNA (Extended Data Fig. 1e and Extended 
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Data Table 1 ). Therefore, we pursued mitochondrial replacement by SCNT with wild-type oocyte mitochondria. Following our reported protocol, two stable nuclear transfer-embryonic stem cell lines were established (Leigh-NT1 and Leigh-NT2) 16 . Genotyping confirmed that both lines contained predominantly oocyte wild-type mtDNA (Extended Data Fig. 1f ) with limited low mutated mtDNA carryover (,1%) at passage 5 that became undetectable upon extended propagation (Extended Data Table 2 ).
Cytogenetic G-banding revealed that Leigh-iPS1 and Leigh-NT1 retained normal diploid karyotypes with no detectable numerical or structural chromosomal abnormalities (Extended Data Fig. 2c ). However, Leigh-NT2 showed a XXXY tetraploid karyotype (Extended Data Fig. 2c ). Fingerprinting by short tandem repeat analysis (STR) also revealed that Leigh-NT2 contained both oocyte and Leigh-fib alleles (Extended Data Table 3 ), consistent with failed enucleation. STR profiles for Leigh-NT1 and Leigh-iPS1 were identical to Leigh-fib (Extended Data Table 3 ). Both Leigh-iPS1 and Leigh-NT1 lines maintained typical PSC morphology, expressed pluripotency markers 7 and formed teratomas containing cells and tissues from all three germ layers (Extended Data Fig. 2d , e). 
Syn, synonymous; non-syn, non-synonymous.
Leigh-fib Whole mtDNA sequencing confirmed the presence of homoplasmic 8993T.G mutation in Leigh-fib and Leigh-iPS1 and also identified a second homoplasmic 4216T.C mutation in the MT-ND1 gene (Extended Data Fig. 1f and Supplementary Table 2 ). This nonsynonymous mutation has been previously associated with Leber's hereditary optic neuropathy 15 . Leigh-NT1 mtDNA sequence differed from Leigh-fib at 47 nucleotide positions. In addition to the pathogenic 8993T.G and 4216T.C mutations, differences included 10 single nucleotide polymorphisms (SNPs) in the D-loop region, 2 in the 16S rRNA gene, 1 in the tRNA-R gene and 34 in protein genes ( Table 2) . We also detected two heteroplasmic variants in Leigh-NT1, four in Leigh-fib and three in Leigh-iPS1 (Supplementary Table 2 ). Clinical symptoms associated with these variants have not been reported.
We measured metabolic function in fibroblasts differentiated from Leigh-NT1, Leigh-iPS1 and Leigh-iPS2 and compared them to parental Leigh-fib and healthy skin fibroblasts from the oocyte donor. As expected, the homoplasmic 8993T.G mutation resulted in low mitochondrial oxidative capacity. In contrast, these respiration defects were absent in fibroblasts differentiated from Leigh-NT1 (Fig. 2a) . Leigh-NT1 also displayed a metabolic profile and OCR/ECAR ratios similar to oocyte donor fibroblasts ( Fig. 2a and Extended Data Fig. 4a ). We observed varying levels of oxidative reserve for Leigh-iPS1 and Leigh-iPS2 compared to parental Leigh-fib (Fig. 2a) , reflecting inherent variability within differentiated fibroblast populations. Both Leigh-NT1 and Leigh-iPS1 effectively generated skeletal muscle cells 17 (Extended Data Fig. 4b) , with Leigh-iPS1 skeletal muscle cells displaying significantly lower ATP turnover (P , 0.05) (Fig. 2b) . Extensive cell death was observed in Leigh-iPS1 during directed cardiomyocyte differentiation (Extended Data Fig. 4c ). These results demonstrate complete functional rescue of mitochondrial activity in Leigh-NT1 through restoration of the wild-type mtDNA. Evolution of mtDNA has resulted in a series of neutral polymorphic variants within the human population often associated with regional migration and adaptation to climate 18 . The largest difference between distant human mtDNA haplotypes has been estimated at 95 SNPs 19 . In the present study, phylogenetic analysis assigned oocyte and Leigh-NT1 mtDNA to the D4a haplotype while the Leigh-iPS1 and Leigh-fib mtDNA haplotype was F1a (Supplementary Table 2 ). D4a is a descendant from the M while F1a comes from the N macro-haplo-group per the human mtDNA mutation tree (Fig. 2c) . Safety evaluations of mitochondrial replacement therapy suggest possible harmful secondary outcomes reflecting nuclear-mitochondrial incompatibility 20, 21 . Despite 'unmatched' donor mtDNA, Leigh-NT1 demonstrated lineage-specific differentiation and restoration of metabolic activity, implying normal nuclear-mitochondrial interaction. We further investigated a hESO-NT1 derived by SCNT from healthy fetal fibroblasts (human dermal fibroblast (HDF)) and IVF-derived hESO-8 carrying identical mtDNA 16 . hESO-NT1 mtDNA differed from HDF at 12 nucleotide positions ( Fig. 2c and Supplementary  Table 3 ). Metabolic profiles in NPCs and cardiomyocytes differentiated from hESO-NT1 and hESO-8 displayed similar metabolic profiles (Extended Data Fig. 5a-e) . Next, we asked whether the 3243A.G Response to oxidative stress
Response to hypoxia . Global gene expression analysis of fibroblasts differentiated from isogenic MELAS lines identified 1,118 differentially expressed genes in mutant and wild-type cells (Extended Data  Fig. 6a ), whereas 2,950 genes were differentially expressed in fibroblasts differentiated from mutant Leigh-iPS1, Leigh-iPS2 and LeighiPS3 compared to the wild-type Leigh-NT1 cells (Extended Data  Fig. 6b) . Hierarchical clustering using a multiple bootstrap resampling algorithm showed that the Leigh-NT1 fibroblasts were similar to hESO-NT1, hESO-NT2, hESO-7 and hESO-8 fibroblasts (Extended Data Fig. 6c ). These findings further support the notion that oocyte mtDNA in Leigh-NT1 interacts normally with nuclear DNA as long as the mtDNA sequence differences are neutral.
MELAS fibroblasts
Next, we asked whether any of the differentially expressed genes were common to both 3243A.G and 8993T.G mutations, and found 345 genes that were shared, 96% of which were overexpressed in the mutant cells (Fig. 3a) . Functional enrichment analysis identified genes associated with a response to hypoxia and oxidative stress 23, 24 ( Fig. 3b, c ; P value ,0.001). However, we did not observe an enrichment of genes associated with metabolism, stress response, epigenetic regulation, and cell signalling, which was reported in a recent MELAS study 13 (Extended Data Fig. 6d ). Finally, we addressed whether the 3243A.G and 8993T.G mutations specifically impact gene expression of mtDNA-encoded transcripts 25 . We found that transcripts expressed from mtDNA accounted for approximately 20% of the total cellular transcriptome, with similar expression levels across different mutations (Extended Data Fig. 7 ; adjusted P value .0.05).
We demonstrate complementary strategies for generating genetically and functionally corrected PSCs for patients with mtDNA disease. For the most common mtDNA syndromes caused by heteroplasmic mutations, generation of multiple iPS cell lines allows recovery of clones with exclusively wild-type mtDNA due to spontaneous segregation of heteroplasmic mtDNA. SCNT enables correction of homoplasmic mutations through replacement with donor mtDNA, and generation of PSCs with transcriptional and epigenetic profiles similar to embryoderived embryonic stem cells 26 . Recovery of metabolic function despite haplotype differences between patient and donor mtDNA suggests that normal nuclear-to-mitochondrial interactions are highly conserved within species. Generation of genetically corrected PSCs from patients with mtDNA disease enables the transition from palliative care to therapeutic interventions based on regenerative medicine.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
The study protocols and informed consent for human subjects were approved by the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board. No statistical methods were used to predetermine sample size. SCNT and iPS cell derivation and culture. Fibroblasts were acquired from Coriell Cell Repositories or donated by patients directly for our study. Fibroblasts were cultured in DMEM F12 medium supplemented with 10% fetal bovine serum (HyClone) and 50 mM uridine. SCNT procedures were performed as described previously 16 . Sendai virus-based reprogramming was carried out according to the manufacturer's protocol (CytoTune-iPS Reprogramming Kit, Life Technologies). Colonies with typical iPS cell morphology were isolated and manually propagated as described previously 26 in Knockout DMEM medium (Invitrogen) supplemented with 20% knockout serum replacement (Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 1 mM L-glutamine (Invitrogen), 0.1 mM b-mercaptoethanol (Sigma), 1 3 penicillin-streptomycin (Invitrogen) and 4 ng ml 21 basic fibroblast growth factor (Sigma was followed with minor modifications. PSCs were collected using collagenase IV (Life Technologies), washed twice with 13 DPBS without calcium and magnesium (Corning Cellgro), and cultured in Neural Induction Medium 1 (NIM-1: 50% Advanced DMEM/F12 (Invitrogen), 50% Neurobasal (Invitrogen), 13 B27 (Invitrogen), 13 N2 (Invitrogen), 2 mM GlutaMAX (Invitrogen) supplemented with 10 ng ml 21 hLIF (Peprotech), 4 mM CHIR99021 (Selleckchem), 3 mM SB431542 (Selleckchem), 2 mM dorsomorphin (Sigma), and 0.1 mM Compound E (EMD Chemicals Inc.)). Cells were cultured in NIM-1 medium for 2 days with daily medium change and then switched to Neural Induction Medium 2 (NIM-2: 50% Advanced DMEM/F12, 50% Neurobasal, 13 N2, 13 B27, 2 mM GlutaMAX and 10 ng ml 21 hLIF, 4 mM CHIR99021, 3 mM SB431542 and 0.1 mM Compound E). After 5 days culture in NIM-2 (daily medium change), cells were treated with 10 mM Y27632 (Selleckchem) for 1 h and 'dome'-shaped colonies were manually picked and treated with Accumax (Innovative Cell Technologies) for 10 min at 37 uC. Cells were then gently pipetted to obtain single cell suspension and replated onto Matrigel-coated 6-well plates at a density 3.5 3 10 4 per cm 2 in Neural Progenitor cell Maintenance Medium (NPMM: 50% Advanced DMEM/F12, 50% Neurobasal, 13 B27, 13 N2, 2 mM GlutaMAX, 10 ng ml 21 hLIF, 3 mM CHIR99021 and 2 mM SB431542) supplemented with 10 mM Y27632. NPCs were maintained on Matrigel-coated dishes in NPMM with daily medium change and passaged upon reaching 70% to 80% confluence using Accumax. Skeletal muscle differentiation. Skeletal muscle differentiation was based on a previous report with minor modifications 17 . Briefly, PSCs plated on Matrigelcoated plates were grown to 40% confluence in mTeSR1 medium and then switched to Skeletal Muscle Induction Medium (SMIM, DMEM/F12, ITS, 3 mM CHIR99021). After 4 days culture in SMIM with daily medium change, cells were cultured in Skeletal Muscle Expansion Medium (SMEM: DMEM/F12, ITS and 20 ng ml 21 FGF2) for an additional 14 days with daily medium change. Cells were then cultured in Skeletal Muscle Differentiation Medium (SMDM: DMEM/F12 and ITS only) for an additional 18 days. Cardiomyocyte differentiation. Cardiomyocyte differentiation was performed with adaptation based on the inhibition of GSK3 and Wnt pathways 15 . Briefly, PSCs were collected after Accutase (Life Technologies) treatment and cultured on Matrigel-coated plates in RPMI supplemented with B27 without insulin (Invitrogen) to 80-90% confluency. Cells were then incubated with 12 mM CHIR99021 (Selleckchem) for 16 h. At day 3, cells were incubated with 5 mM IWP2 (Tocris) for 48 h. At day 7, medium was replaced to RPMI supplemented with complete B27. Medium was replaced every 3 days. Contracting cardiomyocytes were observed on day 12 of differentiation. Immunocytochemistry. Cultured cells were fixed with 4% paraformaldehyde for 15 min at room temperature and then permeabilized with 0.2% Triton X-100 in PBS for 10 min. Cells were washed 33 with PBST (PBS 13, 0.02% Tween-20) and blocked with 10% goat or donkey serum (Sigma) for 1 h at room temperature. Cells were then incubated with primary antibodies diluted in PBST overnight at 4 uC, washed 33 with PBST and incubated with secondary antibodies (1:500, Molecular Probes) for 1 h at room temperature. Cells were washed 33 and mounted in Prolong Gold Antifade Mountant (Life Technologies). Image acquisition was performed on a Zeiss LSM 780 confocal microscope. Primary antibodies were: PAX6 (1:100, Convance), NESTIN (1:200, Millipore), MF20 (1:100, DSHB), OCT4 (1:100, Santa Cruz) and NANOG (1:40, R&D Systems). Teratoma assay. Approximately 3-5 million undifferentiated PSCs were injected into the hindleg muscle of 8-week-old, SCID, beige male mice (Charles River) using an 18-gauge needle. Six to seven weeks after injection, mice were euthanized and tumours were dissected, sectioned and histologically characterized for the presence of representative tissues as described previously 7 . The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. mtDNA heteroplasmy analysis by ARMs-qPCR. The amplification refractory mutation system quantitative PCR assay (ARMs-qPCR) was used to measure mtDNA carryover in Leigh-NT1 and NT2 as previously described 16 . Primers and TaqMan MGB probes were designed to detect the 8993T.G mutation site. The nondiscriminative (ND) and discriminative (D) assays were mixed and measured with Rotor-Gene Multiplex PCR Kit (Qiagen). All reactions were run in duplicate with two different amounts of input DNA: 1-4 ng and 1:8 dilutions. The SDS software generated a standard curve using four eightfold dilutions plus a final fourfold dilution. The percentage of mtDNA carryover in relation to the total mtDNA content was calculated by the equation: heteroplasmy 5 1003(quantity D/quantity ND). ARMs-qPCR was also applied to detect 8993T.G, 3243A.G and 13513G.A heteroplasmy levels in fibroblasts and iPS cells using primers and TaqMan MGB probes specifically targeting to mutation sites. Whole mtDNA sequencing analysis by MiSeq. Single PCR amplification of entire human mtDNA was performed with primers mtDNA-F-2120, (GGAC ACTAGGAAAAAACCTTGTAGAGAGAG) and mtDNA-R-2119 (AAAGAGC TGTTCCTCTTTGGACTAACA) under the following conditions: 94 uC for 1 min followed 98 uC for 10 s and 68 uC for 16 min 330 cycles and then 72 uC for 10 min. PCR amplifications were performed using TAKARA LA Taq polymerase (Takara Biotechnology) and the concentrations of PCR products were measured using a Qubit 2.0 Fluorometer. The Nextera XT DNA sample preparation kit (Illumina) was used to prepare the libraries. Sequencing was performed on an Illumina MiSeq instrument and the data were analysed using NextGENe software. Briefly, sequence reads ranging from 100 to 200 bp were quality filtered and processed using BLAT algorithm. Sequence error correction feature (condensation) was performed to reduce false-positive variants and produce sample consensus sequence and variant calls. Alignment without sequence condensation was used to calculate percentage of mitochondrial genome with depth of coverage of 1,000. Starting from quality FASTQ reads, the reads were quality filtered and converted to FASTA format. Filtered reads were then aligned to the revised Cambridge Reference Sequence (rCRS) of the human mtDNA (NC_012920.1) followed by variant calling. Variant heteroplasmy was calculated by NextGENe software as follows: Base heteroplasmy (mutant allele frequency %) 5 mutant allele (forward 1 reverse)/total coverage of all alleles C, G, T, A (forward 1 reverse) 3 100. The clinical significance of the variants was then analysed with MitoMaster (http:// www.mitomap.org/MITOMASTER/WebHome). Live cell oxygen consumption. XF24 or XF96 extracellular flux analysers (Seahorse Biosciences) were used to measure oxygen consumption rates (OCR) as described 12 . In brief, stem-cell-derived fibroblasts were seeded at a density of 50,000 cells per well of a XF24 cell culture microplate and incubated for 24 h to ensure attachment. Before assay, cells were equilibrated for 1 h in unbuffered XF assay medium supplemented with 25 mM glucose, 1 mM sodium pyruvate, 2 mM glutamax, 13 nonessential amino acids and 1% FBS in a non-CO 2 incubator. Mitochondrial processes were examined through sequential injections of oligomycin (0.5 mg ml
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), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 1 mM) and rotenone (0.5 mM)/antimycin A (1 mM). Indices of mitochondrial function were calculated as basal respiration rate (baseline OCR 2 rotenone/antimycin A OCR), ATP dependent (basal respiration rate 2 oligomycin OCAR), maximal respiration rate (FCCP OCR 2 rotenone/antimycin A OCR) and oxidative reserve (maximal respiration rate 2 basal respiration rate). For other cell types, an XF96 extracellular flux analyser was used with 20,000 cells seeded to each well of a XF96 cell culture microplate. After a 24-h attachment period, mitochondrial processes were examined using the same protocol as above. Each plotted value was normalized to total protein quantified using a Bradford protein assay (Bio-rad). Results were presented as mean 6 s.e.m. One-way ANOVA was used for three group comparisons and Student's t-test was used for two group comparisons. A P value less than 0.05 was considered significant. Flow cytometric analysis. The efficiency of differentiation protocols was assessed by FACS. For cardiomyocyte differentiation, 0.25 million cells were fixed in the presence of 1% (vol/vol) paraformaldehyde at room temperature for 20 min. Fixed cells were then incubated in 90% (vol/vol) cold methanol for 15 min at 4 uC, rinsed LETTER RESEARCH two times and incubated overnight at 4 uC with a primary antibodies against GATA4 (Santa Cruz) and cTnT (Pierce). After staining, cells were rinsed two times and incubated in the presence of 1:1,000 secondary antibodies (donkey Alexa 488 and 567; Molecular Probes) for 30 min. After staining, cells were washed two times and re-suspended for analysis. Real time RT-PCR. RNA was isolated using RNeasy kit (Qiagen) as per manufacturer's instructions. cDNA synthesis was performed using the iScriptTM cDNA synthesis kit for RT-PCR (BioRad). Real-time PCR was performed using the SYBR Green Supermix (BioRad). The levels of expression of respective genes were normalized to corresponding 18S values and are shown as fold change relative to the value of the control sample. All reactions were done in triplicate. RNA-seq library construction and data analysis. RNA was isolated with Microto-Midi Total RNA Purification System (Life Technologies), quality evaluated (RNA6000 Nano Kit and BioAnalyzer 2100, Agilent) made into sequencing libraries, sequenced and mapped as previously described 26 . Libraries were constructed using 500 ng input RNA per sample. Approximately 27 million reads were generated per sample, and 73% of these reads were uniquely mapped. Counts for each gene were quantified using the python script rpkmforgenes and annotated using Ensembl GRCh37. Genes without at least one sample with at least five reads were removed from the analysis. The count data was normalized and differential expression was performed using the R (v.3.1.1) package DESeq2 (v.1.4.5). Briefly, DESeq2 uses negative binomial generalized linear models and shrinkage estimation for dispersions and fold changes to improve stability and interpretability of the estimates 29 . It reports a P value and an adjusted P value using the Benjamini-Hochberg procedure. Genes with an adjusted P value less than 0.05 were considered differentially expressed unless otherwise noted. Heat maps were constructed using the R (v.3.1.1) package gplots (v.2.14.2). Each variable was standardized by subtraction of its mean value and division by its standard deviation across all samples. All functional enrichment analyses were generated using the Genomic Regions Enrichment of Annotations Tool (v. 2.0. 2) 30 with default settings. Hierarchical clustering was performed with the R package pvclust, with Euclidian distance and average linkage with 10,000 bootstraps. 
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Extended Data Figure 6 | RNA-seq analyses of fibroblasts differentiated from MELAS and Leigh syndrome PSCs carrying wild-type and mutant mtDNA. a, Heat map showing all differentially expressed 1,118 genes (adjusted P value , 0.05) between fibroblasts differentiated from mutant MELAS iPS cells (n 5 4 from biological duplicates of MELAS-iPS2 and MELAS-iPS4) and wild-type MELAS iPS cells (n 5 4 from biological duplicates of MELAS-iPS1 and MELAS-iPS3). b, Heat map demonstrating differentially expressed 2,950 genes (adjusted P value , 0.05) between fibroblasts derived from wild-type Leigh-NT1 (biological duplicates) and mutant Leigh iPS cells (n 5 6 from biological duplicates of Leigh-iPS1, Leigh-iPS2 and Leigh-iPS3). c, Hierarchical clustering using Euclidean distance and average linkage using pvclust, which employs a multiple bootstrap resampling algorithm to calculate the approximately unbiased (AU, red) and bootstrap probability (BU, green) values for cluster distinctions. Hierarchical clustering showed that the Leigh-NT1 fibroblasts were similar to hESO-NT1, hESO-NT2, hESO-7 and hESO-8 fibroblasts. d, Mean log 2 normalized counts 6 s.e.m. for genes previously reported to be differentially expressed in MELAS cytoplasmic hybrid clones and involved in metabolic and stress response, signalling pathways and epigenetic modifying processes (wild type fibroblast; n 5 14 from biological duplicates of 7 independent cell lines; mutant fibroblast n 5 10 from biological duplicates of 5 independent cell lines).
Extended Data Figure 7 | RNA-seq analysis of the mitochondrial transcriptome. Circular heat map displaying average expression levels for all mitochondrial genes grouped by sample differentiation status and presence or absence of a mutation in the mitochondrial genome (Fib mutant (including primary fibroblasts and PSC derived fibroblasts) with mutant mtDNA n 5 14, biological duplicates of 7 independent cell lines; Fib wild type (including primary fibroblasts and PSC derived fibroblasts) with wild-type mtDNA n 5 14, biological duplicates of 7 independent cell lines; PSC mutant (undifferentiated IVF-ESC, NT-ESC and iPS cells) with mutant mtDNA n 5 3; PSC wild type (undifferentiated IVF-ESC, NT-ESC and iPS cells) with wildtype mtDNA n 5 12). The expression of mtDNA-encoded genes was similar irrespective of 3243A.G or 8993T.G mutations (adjusted P value .0.05).
